abstract the present invention relates to a method for preventing the formation of rotigotine crystals. more particularly, the present invention relates to a method for preventing the precipitation of rotigotine crystals, comprising a step of mixing rotigotine and one or more crystallization prevention agents selected from the group consisting of fatty alcohols, fatty acids, fatty acid esters, fatty acid amides , and the derivatives thereof, and a transdermally absorbable preparation which comprises rotigotine and crystallization prevention agents. the method and system of the present invention enable the prevention of the precipitation of rotigotine to thus increase stability during long-term storage, and therefore can be effectively applied to the manufacture of rotigotine-containing patches or the like. -------------------------------------------------- -------------------------------------------------- ------ translation of the abstract patent summary: "transdermally absorbable preparation containing rotigotine". The present invention relates to a method for preventing the formation of rotigotine crystals. more particularly, the present invention relates to a method for preventing precipitation of rotigotine crystals, comprising a rotigotine mixing step and one or more crystallization prevention agents selected from the group consisting of fatty alcohols, fatty acids, fatty acid esters, fatty acid amides, and their derivatives, and a transdermally absorbable preparation containing rotigotine and crystallization preventing agents. The method and system of the present invention allows the prevention of rotigotine precipitation to thereby increase stability during long term storage, and therefore can be effectively applied in the manufacture of plasters containing rotigotine or the like.abstract the present invention relates to a method for preventing the formation of rotigotine crystals. more particularly, the present invention relates to a method for preventing t
